Evidence map›Paper›PMID 21108995›Full record

ArticleFitoterapia2011

Developing a library of authenticated Traditional Chinese Medicinal (TCM) plants for systematic biological evaluation--rationale, methods and preliminary results from a Sino-American collaboration.

David M Eisenberg, Eric S J Harris, Bruce A Littlefield, Shugeng Cao, Jane A Craycroft, Robert Scholten, Peter Bayliss, Yanling Fu, Wenquan Wang, Yanjiang Qiao and 9 more

Abstract read
In one paragraph

Article in Fitoterapia, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
6.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Herbal medicines for ischemic stroke: combating inflammation as therapeutic targets.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2014
    Review
  16. Review
  17. Article
  18. Acupuncture and herbal medicine for cancer patients.Evidence-based complementary and alternative medicine : eCAM · 2013
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 3 countries.

David M EisenbergOsher Research Center, Division for Research and Education in Complementary and Integrative Medical Therapies, Harvard Medical School, Boston, MA 02115, USA. David_Eisenberg@hms.harvard.edu
Eric S J Harris
Bruce A Littlefield
Shugeng Cao
Jane A Craycroft
Robert Scholten
Peter Bayliss
Yanling Fu
Wenquan Wang
Yanjiang Qiao
Zhongzhen Zhao
Hubiao Chen
Yong Liu
Ted Kaptchuk
William C Hahn
Xiaoxing Wang
Thomas Roberts
Caroline E Shamu
Jon Clardy
Harvard University · USDana-Farber Cancer Institute · USBeijing University of Chinese Medicine · CNHong Kong Baptist University · HKBeth Israel Deaconess Medical Center · US

Funding

Project 2 - Effects of Herb Fractions on Cell Function/Regulation:U19CA128534 · NCI · HARVARD MEDICAL SCHOOL · PI ROBERTS, THOMAS M · 2006 to 2009
$1.8M
NIR-LED Treatment for Parkinson's DiseaseR21AT003002 · NCCIH · MEDICAL COLLEGE OF WISCONSIN · PI WHELAN, HARRY THOMAS · 2006 to 2007
$384k
US-China-Japan Research Consortium on Herbal MedicinesR21AT001979 · NCCIH · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI EISENBERG, DAVID M · 2003 to 2004
$268k
NCCIH NIH HHS AT03002NCCIH NIH HHS R21 AT001979NCCIH NIH HHS R21 AT003002NCI NIH HHS U19 CA128534
6 · The paper itself

Abstract

While the popularity of and expenditures for herbal therapies (aka "ethnomedicines") have increased globally in recent years, their efficacy, safety, mechanisms of action, potential as novel therapeutic agents, cost-effectiveness, or lack thereof, remain poorly defined and controversial. Moreover, published clinical trials evaluating the efficacy of herbal therapies have rightfully been criticized, post hoc, for their lack of quality assurance and reproducibility of study materials, as well as a lack of demonstration of plausible mechanisms and dosing effects. In short, clinical botanical investigations have suffered from the lack of a cohesive research strategy which draws on the expertise of all relevant specialties. With this as background, US and Chinese co-investigators with expertise in Traditional Chinese Medicine (TCM), botany, chemistry and drug discovery, have jointly established a prototype library consisting of 202 authenticated medicinal plant and fungal species that collectively represent the therapeutic content of the majority of all commonly prescribed TCM herbal prescriptions. Currently housed at Harvard University, the library consists of duplicate or triplicate kilogram quantities of each authenticated and processed species, as well as "detanninized" extracts and sub-fractions of each mother extract. Each species has been collected at 2-3 sites, each separated geographically by hundreds of miles, with precise GPS documentation, and authenticated visually and chemically prior to testing for heavy metals and/or pesticides contamination. An explicit decision process has been developed whereby samples with the least contamination were selected to undergo ethanol extraction and HPLC sub-fractionation in preparation for high throughput screening across a broad array of biological targets including cancer biology targets. As envisioned, the subfractions in this artisan collection of authenticated medicinal plants will be tested for biological activity individually and in combinations (i.e., "complex mixtures") consistent with traditional ethnomedical practice. This manuscript summarizes the rationale, methods and preliminary "proof of principle" for the establishment of this prototype, authenticated medicinal plant library. It is hoped that these methods will foster scientific discoveries with therapeutic potential and enhance efforts to systematically evaluate commonly used herbal therapies worldwide.

Indexed as

Drugs, Chinese HerbalLibrariesMedicine, Chinese TraditionalPhytotherapyPlants, MedicinalChinaCooperative BehaviorDrug DiscoveryHerbal MedicineHumansMateria MedicaUnited StatesDrugs, Chinese HerbalMateria Medica

Identifiers

PMID21108995
PMCPMC3031246
OpenAlexW2015182487

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.